Janusz Rolski

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel et al. · Journal of Clinical Oncology · 2008 · 3.2K citations

Medicine, Oncology, Pharmacology +16

Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study.

DJ Slamon, W. Eiermann, Nicholas J. Robert et al. · Cancer Research · 2009 · 554 citations

Medicine, Oncology, Pharmacology +17

Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment

Kathy S. Albain, Shona Nag, G. Calderillo-Ruiz et al. · Journal of Clinical Oncology · 2008 · 422 citations · Full text

Medicine, Oncology, Pharmacology +17

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Bradley J. Monk, Thomas J. Herzog, Stanley B. Kaye et al. · Journal of Clinical Oncology · 2010 · 404 citations

Medicine, Gynecology, Oncology +16

Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study

J.F.R. Robertson, Antonio Llombart‐Cussac, Janusz Rolski et al. · Journal of Clinical Oncology · 2009 · 312 citations

Medicine, Oncology, Pharmacology +16